MACD Bearish Stocks — Valuation View · Services-Commercial Physical & Biological Research
7 stocks match the MACD Bearish Stocks screen. Stocks whose MACD line is below its signal line — a bearish momentum state, largest first. Valuation columns. Filtered to Services-Commercial Physical & Biological Research. Data as of close · Checked
| IQV | IQVIA | $43.7B | 31.31 | 2.52 | 6.55 | 19.41 | — | 264.87 | +0.43% | 156K |
| MEDP | Medpace Holdings, Inc. | $17.8B | 34.31 | 6.26 | 30.37 | 25.19 | — | 635.08 | -3.25% | 19K |
| CRL | Charles River Laboratories | $15.0B | 373.13 | 3.77 | 4.65 | 74.83 | — | 312.93 | -4.10% | 150K |
| ABSI | Absci Corp | $1.6B | -13.23 | 1026.28 | 6.51 | 14.85 | — | 9.34 | -11.10% | 322K |
| OABI | OmniAb, Inc. | $703M | -16.17 | — | 2.82 | 30.72 | — | 4.82 | -6.86% | 87K |
| MXCT | MAXCYTE, INC. | $134M | -3.76 | — | 0.85 | 8.92 | — | 1.30 | -5.80% | 61K |
| IBAC | IB Acquisition Corp. | $54M | -135.74 | — | — | 1798.32 | — | 10.83 | -0.69% | 310 |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.